3M India (523395) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
27 May, 2026Company overview and operations
Incorporated in 1987, publicly listed since 1991, with three manufacturing facilities, one R&D center, and two customer technical centers in India.
FY 2025-26 sales reached INR 5,090 crores, reflecting 14.5% growth over the previous year.
Workforce comprises approximately 1,273 employees.
Operations are structured into four business groups: Transportation & Electronics, Safety & Industrial, Healthcare, and Consumer.
Each business group posted double-digit sales growth, with Healthcare leading at 17.5%.
Financial performance
FY 2025-26 sales totaled INR 5,090 crores, up 14.5% year-over-year.
Profit before tax (PBT) before exceptional items was INR 960 crores (18.7% of sales), and after exceptional items was INR 894 crores (17.4% of sales).
Profit after tax (PAT) stood at INR 522 crores (10.2% of sales), with an adjusted PAT of INR 662 crores (12.9% of sales).
Cash generation before dividend was INR 483 crores.
Earnings per share increased by 9.7% to INR 463.66.
Strategic initiatives and growth drivers
Focus on commercial excellence, local R&D, supply chain strengthening, and talent development.
Enhanced customer experience and specification wins at key accounts.
Localized product development and leveraging global innovations for the Indian market.
Expansion of manufacturing capacity and outsourcing to support growth.
Culture emphasizes bold aspirations, speed, and performance.
Latest events from 3M India
- Double-digit growth in all segments, robust profits, and a Rs. 506/share dividend proposed.523395
Q4 25/2622 May 2026 - India sales up 13.6% YTD, fueled by innovation, local R&D, and strategic leadership.523395
Investor presentation11 Mar 2026 - Q3 FY26 saw 12.7% sales growth YoY, but a net loss due to exceptional labor and tax charges.523395
Q3 25/2612 Feb 2026 - FY 2024-25 saw 6.1% revenue growth, margin pressure, and a focus on localization and innovation.523395
Status Update13 Nov 2025 - Q2 FY26 delivered 14% sales growth and 43% PAT growth YoY, with broad-based segment gains.523395
Q2 25/263 Nov 2025 - Q1 FY25 profit rose 22% year-over-year on flat revenue, led by Consumer and Safety & Industrial.523395
Q1 24/2525 Aug 2025 - Revenue up 8% YoY, profit and margins down; Health Care leads, cost pressures persist.523395
Q3 24/2525 Aug 2025 - FY25 revenue up 6% with stable EBITDA, but net profit down 18%; Rs. 535/share dividend proposed.523395
Q4 24/2525 Aug 2025 - Sales up 7% YoY, but EBITDA and profit declined amid cost pressures; Health Care led growth.523395
Q2 24/2525 Aug 2025